These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 10233180)

  • 1. Prevention of post-operative recurrence of Crohn's disease requires adequate mucosal concentration of mesalazine. Gruppo Italiano per lo Studio del Colon e del Retto.
    Frieri G; Pimpo MT; Andreoli A; Annese V; Comberlato M; Corrao G; Palumbo G; Sturniolo GC; Tonelli F; Caprilli R
    Aliment Pharmacol Ther; 1999 May; 13(5):577-82. PubMed ID: 10233180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anastomotic configuration and mucosal 5-aminosalicyclic acid (5-ASA) concentrations in patients with Crohn's disease: a GISC study. Gruppo Italiano per lo Studio del Colon e del Retto.
    Frieri G; Pimpo MT; Palumbo G; Tonelli F; Annese V; Sturniolo GC; Andreoli A; Comberlato M; Corrao G; Caprilli R
    Am J Gastroenterol; 2000 Jun; 95(6):1486-90. PubMed ID: 10894584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral mesalazine (5-aminosalicylic acid; Asacol) for the prevention of post-operative recurrence of Crohn's disease. Gruppo Italiano per lo Studio del Colon e del Retto (GISC).
    Caprilli R; Andreoli A; Capurso L; Corrao G; D'Albasio G; Gioieni A; Assuero Lanfranchi G; Paladini I; Pallone F; Ponti V
    Aliment Pharmacol Ther; 1994 Feb; 8(1):35-43. PubMed ID: 8186345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic factors for postoperative recurrence of Crohn's disease. Gruppo Italiano per lo Studio del Colon e del Retto (GISC).
    Caprilli R; Corrao G; Taddei G; Tonelli F; Torchio P; Viscido A
    Dis Colon Rectum; 1996 Mar; 39(3):335-41. PubMed ID: 8603558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two mesalazine regimens in the prevention of the post-operative recurrence of Crohn's disease: a pragmatic, double-blind, randomized controlled trial.
    Caprilli R; Cottone M; Tonelli F; Sturniolo G; Castiglione F; Annese V; Papi C; Viscido A; Cammà C; Corrao G; Latella G
    Aliment Pharmacol Ther; 2003 Feb; 17(4):517-23. PubMed ID: 12622760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Azathioprine versus mesalazine for prevention of postoperative clinical recurrence in patients with Crohn's disease with endoscopic recurrence: efficacy and safety results of a randomised, double-blind, double-dummy, multicentre trial.
    Reinisch W; Angelberger S; Petritsch W; Shonova O; Lukas M; Bar-Meir S; Teml A; Schaeffeler E; Schwab M; Dilger K; Greinwald R; Mueller R; Stange EF; Herrlinger KR;
    Gut; 2010 Jun; 59(6):752-9. PubMed ID: 20551460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. "Crohn's disease activity index" is inaccurate to detect the post-operative recurrence in Crohn's disease. A GISC study. Gruppo Italiano per lo Studio del Colon e del Retto.
    Viscido A; Corrao G; Taddei G; Caprilli R
    Ital J Gastroenterol Hepatol; 1999 May; 31(4):274-9. PubMed ID: 10425569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Addition of mesalazine for subclinical post-surgical endoscopic recurrence of Crohn's disease despite preventive thiopurine therapy: A case-control study.
    Zabana Y; Mañosa M; Cabré E; Bernal I; Marín L; Lorenzo-Zúñiga V; Moreno V; Boix J; Domènech E
    J Gastroenterol Hepatol; 2014; 29(7):1413-7. PubMed ID: 24627958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of Mesalazine, Thiopurines and Tumour Necrosis Factor Antagonists in Preventing Post-Operative Crohn's Disease Recurrence in a Real-Life Setting.
    Allocca M; Landi R; Bonovas S; Fiorino G; Papa A; Spinelli A; Furfaro F; Peyrin-Biroulet L; Armuzzi A; Danese S
    Digestion; 2017; 96(3):166-172. PubMed ID: 28903094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Placebo-controlled clinical trial of mesalazine in the prevention of early endoscopic recurrences after resection for Crohn's disease. Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestives (GETAID).
    Florent C; Cortot A; Quandale P; Sahmound T; Modigliani R; Sarfaty E; Valleur P; Dupas JL; Daurat M; Faucheron JL; Lerebours E; Michot F; Belaiche J; Jacquet N; Soulé JC; Rothman N; Gendre JP; Malafosse M
    Eur J Gastroenterol Hepatol; 1996 Mar; 8(3):229-33. PubMed ID: 8724022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Remaining small bowel endoscopic lesions at surgery have no influence on early anastomotic recurrences in Crohn's disease.
    Klein O; Colombel JF; Lescut D; Gambiez L; Desreumaux P; Quandalle P; Cortot A
    Am J Gastroenterol; 1995 Nov; 90(11):1949-52. PubMed ID: 7484997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early post-operative endoscopic recurrence in Crohn's disease patients: data from an Italian Group for the study of inflammatory bowel disease (IG-IBD) study on a large prospective multicenter cohort.
    Orlando A; Mocciaro F; Renna S; Scimeca D; Rispo A; Lia Scribano M; Testa A; Aratari A; Bossa F; Tambasco R; Angelucci E; Onali S; Cappello M; Fries W; D'Incà R; Martinato M; Castiglione F; Papi C; Annese V; Gionchetti P; Rizzello F; Vernia P; Biancone L; Kohn A; Cottone M
    J Crohns Colitis; 2014 Oct; 8(10):1217-21. PubMed ID: 24630485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of faecal stream diversion on recurrence of Crohn's disease in the neoterminal ileum.
    Rutgeerts P; Goboes K; Peeters M; Hiele M; Penninckx F; Aerts R; Kerremans R; Vantrappen G
    Lancet; 1991 Sep; 338(8770):771-4. PubMed ID: 1681159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Azathioprine and 5-ASA in the prevention of postoperative recurrence of Crohn's disease].
    Nos P; Hinojosa J; Aguilera V; Molés JR; Pastor M; Ponce J; Berenguer J
    Gastroenterol Hepatol; 2000 Oct; 23(8):374-8. PubMed ID: 11227650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mesalazine for the treatment of inflammatory bowel disease.
    Criscuoli V; Modesto I; Orlando A; Cottone M
    Expert Opin Pharmacother; 2013 Aug; 14(12):1669-78. PubMed ID: 23767798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical pharmacokinetics of slow release mesalazine.
    De Vos M
    Clin Pharmacokinet; 2000 Aug; 39(2):85-97. PubMed ID: 10976656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Postoperative recurrence in Crohn's disease. Risk factors and methods of prevention].
    Karoui S; Kallel L; Boubaker J; Filali A
    Tunis Med; 2006 Oct; 84(10):595-8. PubMed ID: 17193847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prolonged-release mesalazine: a review of its therapeutic potential in ulcerative colitis and Crohn's disease.
    Clemett D; Markham A
    Drugs; 2000 Apr; 59(4):929-56. PubMed ID: 10804042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of infliximab therapy after early endoscopic recurrence following ileocolonic resection of Crohn's disease: a prospective pilot study.
    Yamamoto T; Umegae S; Matsumoto K
    Inflamm Bowel Dis; 2009 Oct; 15(10):1460-6. PubMed ID: 19266566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In favour of prophylactic treatment for post-operative recurrence in Crohn's disease.
    Caprilli R; Taddei G; Viscido A
    Ital J Gastroenterol Hepatol; 1998 Apr; 30(2):219-25. PubMed ID: 9675663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.